Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


21.01.2019

19 AIDS
4 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
1 BMC Neurol
1 Cancer
2 HIV Med
12 J Acquir Immune Defic Syndr
1 J Am Acad Dermatol
1 J Infect Dis
1 Lancet Gastroenterol Hepatol
1 Lancet Respir Med
1 Pediatr Infect Dis J
1 Pediatrics
2 PLoS Biol
2 PLoS Med
10 PLoS One
1 PLoS Pathog
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. MAURICE JB, Garvey L, Tsochatzis EA, Wiltshire M, et al
    Monocyte-Macrophage activation is associated with NAFLD and liver fibrosis in HIV mono-infection independently of the gut microbiome and bacterial translocation.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002133.
    PubMed     Text format     Abstract available

  2. DIRAJLAL-FARGO S, Mussi-Pinhata MM, Weinberg A, Yu Q, et al
    HIV-exposed uninfected infants have increased inflammation and monocyte activation.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002128.
    PubMed     Text format     Abstract available

  3. LUPO J, Germi R, Lancar R, Algarte-Genin M, et al
    Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern cART era.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002129.
    PubMed     Text format     Abstract available

  4. HOOTS BE, Wejnert C, Martin A, Haaland R, et al
    Undisclosed HIV infection among men who have sex with men in National HIV Behavioral Surveillance, 2014.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002147.
    PubMed     Text format     Abstract available

  5. COOK RR, Fulcher JA, Tobin NH, Li F, et al
    Effects of HIV viremia on the gastrointestinal microbiome of young men who have sex with men.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002132.
    PubMed     Text format     Abstract available

  6. SPINELLI MA, Glidden DV, Rodrigues WC, Wang G, et al
    Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a PrEP demonstration project.
    AIDS. 2018 Aug 14. doi: 10.1097/QAD.0000000000002135.
    PubMed     Text format     Abstract available

  7. NEWSUM AM, Kooij KW, Boyd A, Smit C, et al
    Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002138.
    PubMed     Text format     Abstract available

  8. BRITTAIN K, Phillips TK, Zerbe A, Abrams EJ, et al
    Long-term effects of unintended pregnancy on antiretroviral therapy outcomes among South African women living with HIV.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002139.
    PubMed     Text format     Abstract available

  9. KIM BH, Kelschenbach J, Borjabad A, Hadas E, et al
    Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HAND in EcoHIV-infected mice.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002150.
    PubMed     Text format     Abstract available

  10. KRONFLI N, Bhatnagar SR, Hull MW, Moodie EEM, et al
    Trends in cause-specific mortality in HIV-Hepatitis C co-infection following hepatitis C treatment scale-up.
    AIDS. 2019 Jan 12. doi: 10.1097/QAD.0000000000002156.
    PubMed     Text format     Abstract available

  11. CHAISSON LH, Semitala FC, Asege L, Mwebe S, et al
    Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002130.
    PubMed     Text format     Abstract available

  12. TATE JP, Sterne JAC, Justice AC
    Improved discrimination of mortality with Veterans Aging Cohort Study (VACS) Index 2.0 in HIV-positive individuals.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002140.
    PubMed     Text format     Abstract available

  13. STOPARD IJ, Mcgillen JB, Hauck K, Hallett TB, et al
    The influence of constraints on the efficient allocation of resources for HIV prevention: a modelling study.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002158.
    PubMed     Text format     Abstract available

  14. WEBEL AR, Jenkins T, Vest M, Oliveria VHF, et al
    Cardiorespiratory fitness is associated with inflammation and physical activity in HIV+ adults.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002154.
    PubMed     Text format     Abstract available

  15. LING L, Wu T, To KKW, Cheung KW, et al
    Vedolizumab-mediated integrin alpha4beta7 blockade does not control HIV-1SF162 rebound after cART interruption in humanized mice.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002149.
    PubMed     Text format     Abstract available

  16. SESSA L, Reddel S, Manno E, Quagliariello A, et al
    Distinct gut microbiota profile in ART-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002131.
    PubMed     Text format     Abstract available

  17. HUA S, Scott JM, Hanna DB, Haberlen SA, et al
    Plasma acylcarnitines and progression of carotid artery atherosclerosis in HIV infection.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002142.
    PubMed     Text format     Abstract available

  18. ASHARE RL, Thompson M, Leone F, Metzger D, et al
    Differences in the rate of nicotine metabolism among smokers with and without HIV.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002127.
    PubMed     Text format     Abstract available

  19. PHILLIPS NJ, Thomas KGF, Myer L, Sacktor N, et al
    Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: y-IHDS validation.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002144.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  20. BHUKAR R, Sachdeva RK, Suri D, Shandilya J, et al
    Reduced NK Cell subsets in perinatally acquired long term non progressors HIV infected children.
    AIDS Res Hum Retroviruses. 2019 Jan 11. doi: 10.1089/AID.2018.0243.
    PubMed     Text format     Abstract available

  21. SWANSTROM AE, Jacques A, Del Prete G, Bieniasz P, et al
    Short Communication: Ultrasensitive Immunoassay for Assessing Residual Simian-Tropic HIV (stHIV) in Non-Human Primate Models of AIDS.
    AIDS Res Hum Retroviruses. 2019 Jan 11. doi: 10.1089/AID.2018.0278.
    PubMed     Text format     Abstract available

  22. MCKINNON LR, Achilles S, Bradshaw CS, Burgener A, et al
    The evolving facets of bacterial vaginosis: implications for HIV transmission.
    AIDS Res Hum Retroviruses. 2019 Jan 14. doi: 10.1089/AID.2018.0304.
    PubMed     Text format     Abstract available

  23. KOBE JB, Talbot O, Chen I, Eshleman SH, et al
    Viral genetic linkage analysis among Black men who have sex with men (HIV Prevention Trials Network 061).
    AIDS Res Hum Retroviruses. 2019 Jan 14. doi: 10.1089/AID.2018.0204.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  24. BEDNASZ CJ, Venuto CS, Ma Q, Daar ES, et al
    Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202.
    Antimicrob Agents Chemother. 2019 Jan 14. pii: AAC.01638.
    PubMed     Text format     Abstract available


    BMC Neurol

  25. MUSUBIRE AK, Meya DB, Katabira ET, Meyer ACL, et al
    Epidemiology of non-traumatic spinal cord injury in Uganda: a single center, prospective study with MRI evaluation.
    BMC Neurol. 2019;19:10.
    PubMed     Text format     Abstract available


    Cancer

  26. CORRIGAN KL, Wall KC, Bartlett JA, Suneja G, et al
    Cancer disparities in people with human immunodeficiency virus: A systematic review of screening for non-AIDS-defining malignancies.
    Cancer. 2019 Jan 15. doi: 10.1002/cncr.31838.
    PubMed     Text format     Abstract available


    HIV Med

  27. DAKSHINA S, Olaru ID, Khan P, Raman L, et al
    Evaluation of weight-based prescription of antiretroviral therapy in children.
    HIV Med. 2019 Jan 11. doi: 10.1111/hiv.12702.
    PubMed     Text format     Abstract available

  28. KRENTZ HB, Campbell S, Lahl M, Gill MJ, et al
    De-simplifying single-tablet antiretroviral treatments: uptake, risks and cost savings.
    HIV Med. 2019 Jan 11. doi: 10.1111/hiv.12701.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  29. VENTER WDF, Kambugu A, Chersich MF, Becker S, et al
    Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial.
    J Acquir Immune Defic Syndr. 2019;80:224-233.
    PubMed     Text format     Abstract available

  30. ARRINGTON-SANDERS R, Wilson CM, Perumean-Chaney SE, Patki A, et al
    Brief Report: Role of Sociobehavioral Factors in Subprotective TFV-DP Levels Among YMSM Enrolled in 2 PrEP Trials.
    J Acquir Immune Defic Syndr. 2019;80:160-165.
    PubMed     Text format     Abstract available

  31. GOGIA S, Zanni MV
    Authors' Reply to Comments on "Cardiovascular Risk Profile of Transgender Women with HIV: A U.S. Healthcare Database Study".
    J Acquir Immune Defic Syndr. 2019 Jan 9. doi: 10.1097/QAI.0000000000001944.
    PubMed     Text format    

  32. BAUMANN A, Musaazi J, Kambugu A, Kalin M, et al
    Virological outcome of patients with HIV drug resistance attending an urban out-patient clinic in Uganda: a need for structured adherence counselling and third line treatment options.
    J Acquir Immune Defic Syndr. 2019 Jan 9. doi: 10.1097/QAI.0000000000001943.
    PubMed     Text format     Abstract available

  33. MINNIS AM, Browne EN, Boeri M, Agot K, et al
    Young women's stated preferences for biomedical HIV prevention: results of a discrete choice experiment in Kenya and South Africa.
    J Acquir Immune Defic Syndr. 2019 Jan 9. doi: 10.1097/QAI.0000000000001945.
    PubMed     Text format     Abstract available

  34. SHERMAN SG, Park JN, Galai N, Allen ST, et al
    Drivers of HIV infection among cisgender and transgender female sex worker populations in Baltimore city: Results from the SAPPHIRE study.
    J Acquir Immune Defic Syndr. 2019 Jan 8. doi: 10.1097/QAI.0000000000001959.
    PubMed     Text format     Abstract available

  35. RADWAN D, Cachay E, Falade-Nwulia O, Moore RD, et al
    HCV Screening and Treatment Uptake among Patients in HIV care During 2014-2015.
    J Acquir Immune Defic Syndr. 2019 Jan 8. doi: 10.1097/QAI.0000000000001949.
    PubMed     Text format     Abstract available

  36. AKILIMALI NA, Muema DM, Specht C, Chang CC, et al
    Cryptococcosis-associated Immune Reconstitution Inflammatory Syndrome is associated with Dysregulation of IL-7/IL-7 Receptor Signaling Pathway in T-cells and Monocyte Activation.
    J Acquir Immune Defic Syndr. 2019 Jan 8. doi: 10.1097/QAI.0000000000001946.
    PubMed     Text format     Abstract available

  37. KATZ DA, Dombrowski JC, Barry M, Spellman D, et al
    STD Partner Services to Monitor and Promote HIV Pre-Exposure Prophylaxis Use Among Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2019 Jan 8. doi: 10.1097/QAI.0000000000001952.
    PubMed     Text format     Abstract available

  38. MAHEU-GIROUX M, Diabate S, Boily MC, Jean-Paul N, et al
    Cost-Effectiveness of Accelerated HIV Response Scenarios in Cote d'Ivoire.
    J Acquir Immune Defic Syndr. 2019 Aug 1. doi: 10.1097/QAI.0000000000001956.
    PubMed     Text format     Abstract available

  39. SAKABUMI DZ, Moore RC, Tang B, Delaney PA, et al
    Chronic Distal Sensory Polyneuropathy is a Major Contributor to Balance Disturbances in Persons Living with HIV.
    J Acquir Immune Defic Syndr. 2019 Jan 3. doi: 10.1097/QAI.0000000000001953.
    PubMed     Text format     Abstract available

  40. PATEL AS, Goparaju L, Sales JM, Mehta CC, et al
    PrEP Eligibility among At-Risk Women in the Southern US: Associated Factors, Awareness and Acceptability.
    J Acquir Immune Defic Syndr. 2019 Jan 3. doi: 10.1097/QAI.0000000000001950.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  41. REKHTMAN S, Strunk A, Garg A
    Incidence of Pneumocystosis Among Patients Exposed to Immunosuppression.
    J Am Acad Dermatol. 2019 Jan 9. pii: S0190-9622(19)30058.
    PubMed     Text format     Abstract available


    J Infect Dis

  42. MATHUR R, Hui Q, Huang Y, Gwinn M, et al
    DNA Methylation Markers of Type 2 Diabetes among HIV-Positive and -Negative Male Veterans.
    J Infect Dis. 2019 Jan 11. pii: 5288496. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  43. COOKE GS, Andrieux-Meyer I, Applegate TL, Atun R, et al
    Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.
    Lancet Gastroenterol Hepatol. 2019;4:135-184.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  44. VON GROOTE-BIDLINGMAIER F, Patientia R, Sanchez E, Balanag V Jr, et al
    Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial.
    Lancet Respir Med. 2019 Jan 7. pii: S2213-2600(18)30426.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  45. LOUIS FJ, Segaren N, Desinor O, Beard RS, et al
    High Levels of HIV-1 Drug Resistance in Children Who Acquired HIV Infection Through Mother to Child Transmission in the Era of Option B+, Haiti, 2013-2014.
    Pediatr Infect Dis J. 2018 Dec 27. doi: 10.1097/INF.0000000000002270.
    PubMed     Text format     Abstract available


    Pediatrics

  46. CHAKRABORTY R, Rathore MH, Dreyer BP, Stein F, et al
    The Pivotal Role of the International Medical Graduate.
    Pediatrics. 2019 Jan 10. pii: peds.2018-1189. doi: 10.1542/peds.2018-1189.
    PubMed     Text format    


    PLoS Biol

  47. CANALS R, Hammarlof DL, Kroger C, Owen SV, et al
    Adding function to the genome of African Salmonella Typhimurium ST313 strain D23580.
    PLoS Biol. 2019;17:e3000059.
    PubMed     Text format     Abstract available

  48. IVAN B, Sun Z, Subbaraman H, Friedrich N, et al
    CD4 occupancy triggers sequential pre-fusion conformational states of the HIV-1 envelope trimer with relevance for broadly neutralizing antibody activity.
    PLoS Biol. 2019;17:e3000114.
    PubMed     Text format     Abstract available


    PLoS Med

  49. TENFORDE MW, Walker AS, Gibb DM, Manabe YC, et al
    Rapid antiretroviral therapy initiation in low- and middle-income countries: A resource-based approach.
    PLoS Med. 2019;16:e1002723.
    PubMed     Text format     Abstract available

  50. LOW AJ, Frederix K, McCracken S, Manyau S, et al
    Association between severe drought and HIV prevention and care behaviors in Lesotho: A population-based survey 2016-2017.
    PLoS Med. 2019;16:e1002727.
    PubMed     Text format     Abstract available


    PLoS One

  51. MACHNOWSKA P, Meixenberger K, Schmidt D, Jessen H, et al
    Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort.
    PLoS One. 2019;14:e0209605.
    PubMed     Text format     Abstract available

  52. VARKILA MRJ, Vos AG, Barth RE, Tempelman HA, et al
    The association between HIV infection and pulmonary function in a rural African population.
    PLoS One. 2019;14:e0210573.
    PubMed     Text format     Abstract available

  53. KALEMBO FW, Kendall GE, Ali M, Chimwaza AF, et al
    Socio-demographic, clinical, and psychosocial factors associated with primary caregivers' decisions regarding HIV disclosure to their child aged between 6 and 12 years living with HIV in Malawi.
    PLoS One. 2019;14:e0210781.
    PubMed     Text format     Abstract available

  54. SABERI P, Ming K, Legnitto D, Neilands TB, et al
    Feasibility and acceptability of novel methods to estimate antiretroviral adherence: A longitudinal study.
    PLoS One. 2019;14:e0210791.
    PubMed     Text format     Abstract available

  55. BAHEMUKA UM, Abaasa A, Ruzagira E, Lindan C, et al
    Retention of adults from fishing communities in an HIV vaccine preparedness study in Masaka, Uganda.
    PLoS One. 2019;14:e0198460.
    PubMed     Text format     Abstract available

  56. BALDE A, Lang S, Wagner A, Ferrieres J, et al
    Trends in the risk of myocardial infarction among HIV-1-infected individuals relative to the general population in France: Impact of gender and immune status.
    PLoS One. 2019;14:e0210253.
    PubMed     Text format     Abstract available

  57. MUKUMBANG FC, van Wyk B, Van Belle S, Marchal B, et al
    Unravelling how and why the Antiretroviral Adherence Club Intervention works (or not) in a public health facility: A realist explanatory theory-building case study.
    PLoS One. 2019;14:e0210565.
    PubMed     Text format     Abstract available

  58. CARLOS S, Lopez-Del Burgo C, Ndarabu A, Osorio A, et al
    Heterosexual oral and anal sex in Kinshasa (D.R.Congo): Data from OKAPI prospective cohort.
    PLoS One. 2019;14:e0210398.
    PubMed     Text format     Abstract available

  59. GEJO NG, Weldearegay HG, W/Tinsaie KT, Mekango DE, et al
    Exclusive breastfeeding and associated factors among HIV positive mothers in Northern Ethiopia.
    PLoS One. 2019;14:e0210782.
    PubMed     Text format     Abstract available


  60. Correction: Clinical, virological and immunological features of HIV-positive children internationally adopted in France from 2005-2015.
    PLoS One. 2019;14:e0210933.
    PubMed     Text format     Abstract available


    PLoS Pathog

  61. LI Z, Wu J, Chavez L, Hoh R, et al
    Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency.
    PLoS Pathog. 2019;15:e1007498.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  62. MARTINS MA, Bischof GF, Shin YC, Lauer WA, et al
    Vaccine protection against SIVmac239 acquisition.
    Proc Natl Acad Sci U S A. 2019 Jan 14. pii: 1814584116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: